Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.

Podobne zapisy

• Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.
  od: Patick, A K, i wsp.
  Wydane: (1996)
• ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
  od: Kempf, D J, i wsp.
  Wydane: (1995)
• CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.
  od: Alteri, E, i wsp.
  Wydane: (1993)
• From nonpeptide toward noncarbon protease inhibitors: Metallacarboranes as specific and potent inhibitors of HIV protease
  od: Cígler, Petr, i wsp.
  Wydane: (2005)
• Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.
  od: Poppe, S M, i wsp.
  Wydane: (1997)